Cancer deaths among Black men and women in the United States have declined during the past decade in the United States, a new ...

Nichols said those factors and the length of time before diagnosis greatly impact mortality rates for individuals with multiple myeloma. “Five-year relative survival rates for multiple myeloma ...

The overall five-year survival rate for people with active multiple myeloma in the United States has increased steadily over time, to more than 62% today. It’s important to remember that even the most ...

Although the treatment of myeloma has changed dramatically after the readout of many recent trials, key unanswered questions ...

Black individuals had a 2-fold risk of cancer death related to prostate, myeloma, and stomach cancers compared with White ...

Multiple myeloma (MM), which is caused by ... can insert into the cell membrane and inhibit activation of AKT1, leading to myeloma cell death 10. Perifosine might also augment the impact of ...

The FDA accepted Regeneron’s BLA resubmission for linvoseltamab in relapsed or refractory multiple myeloma, with a decision expected by July 10, 2025.

Daratumumab plus VRd significantly improves survival in newly diagnosed multiple myeloma, supporting its role as a new ...

A five-year study has found that adding daratumumab (D) to the current standard-of-care triplet therapy bortezomib, lenalidomide, and dexamethasone (VRd) produced deeper and more durable minimal ...